Alar Pharmaceuticals Inc (6785)

Currency in TWD
59.70
-6.60(-9.95%)
Closed·
Advertisement
Trading near 52-week Low
6785 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
59.7065.20
52 wk Range
59.7087.50
Key Statistics
Prev. Close
-
Open
65.2
Day's Range
59.7-65.2
52 wk Range
59.7-87.5
Volume
198.63K
Average Volume (3m)
53.99K
1-Year Change
-
Book Value / Share
35.42
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6785 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Earnings

Latest Release
20/11/2026
EPS / Forecast
-0.17 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.84
Dividend Yield
-
Industry Median 3.41%
Annualised payout
0.10
Paid annually
5-Years Growth
-
Growth Streak

Compare 6785 to Peers and Sector

Metrics to compare
6785
Peers
Sector
Relationship
P/E Ratio
−78.8x−3.6x−0.2x
PEG Ratio
0.880.180.00
Price/Book
1.9x1.4x2.6x
Price / LTM Sales
1,476.3x5.0x2.6x
Upside (Analyst Target)
-0.0%76.9%
Fair Value Upside
Unlock74.4%14.9%Unlock

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
17.00K0.03%1.13M
Other Institutional Investors
15.17M22.71%1.01B
Public Companies & Retail Investors
51.61M77.26%3.42B
Total
66.8M100.00%4.43B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
CDIB Capital Healthcare Ventures Ltd.7.94%5,301,000351,456
Fubon Financial Holding Venture Capital Co., Ltd.4.60%3,072,000203,674

FAQ

What Is the Alar Pharmaceuticals (TPEX: 6785) Share Price Today?

The Alar Pharmaceuticals stock price today is 59.70 TWD.

What Stock Exchange Does Alar Pharmaceuticals (6785) Trade On?

Alar Pharmaceuticals is listed and trades on the Taipei Exchange.

What Is the Ticker (Stock Symbol) for Alar Pharmaceuticals?

The stock symbol (also called a 'ticker') for Alar Pharmaceuticals is "6785."

Does Alar Pharmaceuticals Pay Dividends? What’s The Current 6785 Dividend Yield?

Yes, 6785 Pays Dividends to its Shareholders. The current Alar Pharmaceuticals dividend yield is 0.2%%.

What Is the Current Alar Pharmaceuticals Market Capitalisation?

As of today, Alar Pharmaceuticals (TPEX: 6785) market cap is 3.99B TWD.

What Is Alar Pharmaceuticals's (6785) Earnings Per Share (TTM)?

The Alar Pharmaceuticals EPS is currently -0.84 (Trailing Twelve Months).

Is 6785 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Alar Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for 6785 stock is Sell.

How Many Times Has Alar Pharmaceuticals Stock Split?

Alar Pharmaceuticals has split 0 times. (See the 6785 stock split history page for full effective split date and price information.)

What is the current trading status of Alar Pharmaceuticals (TPEX: 6785)?

As of 21/11/2026, Alar Pharmaceuticals (6785) is trading at a share price of 59.70 TWD, with a previous close of 0.00 TWD. The stock has fluctuated within a day range of 59.70 TWD to 65.20 TWD, while its 52-week range spans from 59.70 TWD to 87.50 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.